Rutaiwan Tohtong Selected Research

Galactans

12/2017	Sulfated galactans from the red seaweed Gracilaria fisheri exerts anti-migration effect on cholangiocarcinoma cells.
1/2017	Sulfated Galactans from Red Seaweed Gracilaria fisheri Target EGFR and Inhibit Cholangiocarcinoma Cell Proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rutaiwan Tohtong Research Topics

Disease

18	Cholangiocarcinoma 08/2022 - 10/2006
17	Neoplasms (Cancer) 01/2022 - 01/2005
4	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2006
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Margins of Excision 04/2021
1	Carcinogenesis 08/2020
1	Hypercholesterolemia 11/2019
1	Herpes Zoster 03/2018
1	Biliary Tract Diseases 01/2015

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 08/2022 - 01/2012
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
3	Small Interfering RNA (siRNA)IBA 12/2011 - 11/2006
3	Matrix Metalloproteinases (MMPs)IBA 12/2011 - 01/2005
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2015
2	Protein Kinases (Protein Kinase)IBA 10/2020 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2020 - 06/2006
2	Polysaccharides (Glycans)IBA 12/2017 - 01/2017
2	GalactansIBA 12/2017 - 01/2017
1	Serine (L-Serine)FDA Link 08/2022
1	Arginine (L-Arginine)FDA Link 08/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022
1	1- (2,3- dichlorobenzoyl)- 5- methoxy- 2- methyl- (2- (mopholin- 4- yl)ethyl)- 1H- indoleIBA 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	EndocannabinoidsIBA 01/2022
1	Cytotoxins (Cytolysins)IBA 04/2021
1	Tyrosine Kinase InhibitorsIBA 04/2021
1	ErbB Receptors (EGF Receptor)IBA 04/2021
1	pembrolizumabIBA 12/2020
1	AntibodiesIBA 12/2020
1	Immune Checkpoint InhibitorsIBA 12/2020
1	NivolumabIBA 12/2020
1	Toll-Like Receptor 3IBA 10/2020
1	LigandsIBA 10/2020
1	MicroRNAs (MicroRNA)IBA 08/2020
1	Gemcitabine FDA Link 01/2020
1	CholesterolIBA 11/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2019
1	LipidsIBA 11/2019
1	Simvastatin (Zocor)FDA LinkGeneric 11/2019
1	CarcinogensIBA 03/2018
1	VimentinIBA 03/2018
1	Cadherins (E-Cadherin)IBA 03/2018
1	Claudin-1IBA 03/2018
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2017
1	Cetuximab (Erbitux)FDA Link 12/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2017
1	Growth Factor ReceptorsIBA 01/2017
1	Tumor Biomarkers (Tumor Markers)IBA 01/2015
1	CXCR ReceptorsIBA 11/2013
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2012
1	Plasminogen InactivatorsIBA 01/2012
1	Messenger RNA (mRNA)IBA 01/2012
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2012
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2012
1	PlasminogenIBA 01/2012
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2012
1	GelatinIBA 01/2012
1	Lipocalin-2IBA 05/2010
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2006
1	U 0126 (UO 126)IBA 11/2006
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2006
1	Proto-Oncogene Proteins c-metIBA 11/2006
1	Bovine Serum AlbuminIBA 10/2006
1	curcusone BIBA 01/2005
1	matrigelIBA 01/2005

Therapy/Procedure

6	Therapeutics 09/2021 - 01/2005
1	Immunotherapy 12/2020
1	Traditional Medicine (Folk Remedies) 01/2005